Document Detail


The inhibitory action of buformin, a biguanide on gluconeogenesis from alanine and its transport system in rat livers.
MedLine Citation:
PMID:  8472619     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effect of buformin, a biguanide, on gluconeogenesis from 10 mM alanine in the presence of 143 nM glucagon were studied using isolated rat liver perfusions. In addition, to investigate possible mechanisms of biguanide action, alanine utilization in isolated rat liver perfusion and [3H]alanine uptake in isolated hepatocytes were observed. Buformin (1.85 mM) strongly inhibited gluconeogenesis from alanine in the presence of glucagon in both normal and streptozocin-induced diabetic rat livers. This inhibition was followed by a decrease in alanine utilization. Both of these inhibitory effects of buformin were dose-dependent. [3H]Alanine uptake was significantly inhibited by buformin. The effect of this agent was similar to but weaker than that of ouabain. However, tolbutamide failed to reduce either alanine utilization or [3H]alanine uptake, although this drug significantly inhibited gluconeogenesis from alanine. These data suggest that biguanides may reduce hepatic alanine utilization via the inhibition of Na+/L-alanine transport activity as one possible mechanism, resulting the inhibition of gluconeogenesis from alanine in the presence of glucagon.
Authors:
N Hotta; T Komori; M Kobayashi; F Sakakibara; N Koh; N Sakamoto
Related Documents :
8134019 - Dopamine output upon death reflects intraneuronal aspects while alive: accumulation of ...
702339 - Kinetics of metabolite formation and elimination in the perfused rat liver preparation:...
653519 - Metabolism of synthetic human heptadecapeptide gastrin by the isolated perfused rat liver.
7131599 - Phagocytosis of colloidal carbon in perfused liver of rats and rabbits.
9186859 - Estrogen effects on the renal handling of calcium in the ovariectomized perfused rat.
3465329 - Prostaglandins: a possible mediator to inhibit hepatic drug metabolism in adjuvant arth...
8508479 - Alteration of hepatic dna synthesis in rats treated with n-nitrosodimethylamine during ...
20146019 - Convulsive activity in the electroencephalogram in rats sensitive and tolerant to penty...
2918399 - Fractional contributions to total carnitine in the neonatal rat.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Diabetes research and clinical practice     Volume:  19     ISSN:  0168-8227     ISO Abbreviation:  Diabetes Res. Clin. Pract.     Publication Date:  1993 Jan 
Date Detail:
Created Date:  1993-05-17     Completed Date:  1993-05-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8508335     Medline TA:  Diabetes Res Clin Pract     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  49-58     Citation Subset:  IM    
Affiliation:
Third Department of Internal Medicine, Nagoya University School of Medicine, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
3-Hydroxybutyric Acid
Acetoacetates / metabolism
Alanine / drug effects,  pharmacokinetics*
Animals
Biological Transport, Active / drug effects
Buformin / pharmacology*
Cell Separation
Diabetes Mellitus, Experimental / metabolism
Glucagon / pharmacology
Gluconeogenesis / drug effects*
Hydroxybutyrates / metabolism
Lactates / metabolism
Lactic Acid
Liver / drug effects*,  metabolism
Male
Perfusion
Pyruvates / metabolism
Pyruvic Acid
Rats
Rats, Wistar
Tolbutamide / pharmacology
Chemical
Reg. No./Substance:
0/Acetoacetates; 0/Hydroxybutyrates; 0/Lactates; 0/Pyruvates; 127-17-3/Pyruvic Acid; 300-85-6/3-Hydroxybutyric Acid; 50-21-5/Lactic Acid; 541-50-4/acetoacetic acid; 56-41-7/Alanine; 64-77-7/Tolbutamide; 692-13-7/Buformin; 9007-92-5/Glucagon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Assessment of pupillary responses to light with IRIS.
Next Document:  Factors influencing the clinical outcome of continuous subcutaneous insulin infusion in routine prac...